World Bank Probes Fraud, Corruption In Drug-Funded Projects In India
This article was originally published in PharmAsia News
The World Bank says "serious incidents of fraud and corruption" have occurred in India and $570 million worth of health projects funded by the global organization. The Bank said it and the Indian government are investigating whether companies that bid on contracts to supply drugs or other material for the projects were involved or whether Bank or government officials were involved. A two-year-old internal review discovered problems in five projects dealing with AIDS, malaria, tuberculosis and other diseases going back to 1997. (Click here for more - may require a subscription
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.